Background: Early diagnosis and intervention are essential for improving the prognosis and survival of gastric cancer (GC) patients. However, specific biomarkers for early GC diagnosis are still unavailable.
Methods: Data-independent acquisition (DIA) proteomics was employed to identify differentially expressed proteins (DEPs) between GC and adjacent non-tumor tissues. Functional and pathway enrichment analyses were conducted, with subsequent genomic-level validation. Methyltransferase-like 7A (METTL7A) expression in GC versus adjacent tissues was confirmed via tissue microarray analysis. Correlations between METTL7A expression, clinical characteristics, and immune infiltration were also explored. Additionally, co-expressed genes related to METTL7A were analyzed, and gene set variation analysis (GSVA) was performed.
Results: DIA proteomics identified 84 DEPs, mainly involved in protein binding and enriched in complement and coagulation pathways. Eight DEPs overlapped with results from the gene expression omnibus (GEO) dataset. METTL7A expression was significantly lower in GC tissues compared to adjacent tissues, confirmed at the genomic level. The cancer genome atlas (TCGA) analysis revealed an area under the receiver operating characteristic (ROC) curve (AUC) of 0.81, with METTL7A expression inversely correlated with age (p = 7.307e-05). Tissue microarray analysis further confirmed reduced METTL7A expression in GC tissues (p = 0.000). METTL7A expression was positively correlated with activated B cells and negatively correlated with activated CD4 T cells.
Conclusions: METTL7A is a promising biomarker for early GC diagnosis.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.7754/Clin.Lab.2024.240701 | DOI Listing |
Background: Early diagnosis and intervention are essential for improving the prognosis and survival of gastric cancer (GC) patients. However, specific biomarkers for early GC diagnosis are still unavailable.
Methods: Data-independent acquisition (DIA) proteomics was employed to identify differentially expressed proteins (DEPs) between GC and adjacent non-tumor tissues.
bioRxiv
January 2025
Department of Genetics, Yale School of Medicine, New Haven, CT 06520, USA.
In mammalian cells, gene copy number is tightly controlled to maintain gene expression and genome stability. However, a common molecular feature across cancer types is oncogene amplification, which promotes cancer progression by drastically increasing the copy number and expression of tumor-promoting genes. For example, in tyrosine kinase inhibitor (TKI)-resistant lung adenocarcinoma (LUAD), oncogene amplification occurs in over 40% of patients' tumors.
View Article and Find Full Text PDFSci Rep
February 2025
Department of Neurology, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, 830000, China.
Background: Melatonin (MLT) can improve mitophagy, thereby ameliorating cognitive deficits in Alzheimer's disease (AD) patients. Hence, our research focused on the potential value of MLT-related genes (MRGs) in AD through bioinformatic analysis.
Methods: First, the key cells in the single-cell dataset GSE138852 were screened out based on the proportion of annotated cells and Fisher's test between the AD and control groups.
Biol Reprod
January 2025
Department of Animal Sciences, Genetics Institute, University of Florida, Gainesville, FL, USA.
In vitro fertilization (IVF) is a widely used assisted reproductive technology to achieve a successful pregnancy. However, the acquisition of oxidative stress in embryo in vitro culture impairs its competence. Here, we demonstrated that a nuclear coding gene, methyltransferase-like protein 7A (METTL7A), improves the developmental potential of bovine embryos.
View Article and Find Full Text PDFMol Biol Rep
January 2025
Department of Genetics, Faculty of Advanced Science and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
Background: The methyltransferase gene family is known for its diverse biological functions and critical role in tumorigenesis. This study aimed to identify these family genes in common gastrointestinal (GI) cancers using comprehensive methodologies.
Methods: Gene identification involved analysis of scientific literature and insights from The Cancer Genome Atlas (TCGA) database.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!